Monoclonal expand into neural disorders

Article Abstract:

Pfizer acquired Rinat Neuroscience in deal worth $500 million approximately in April 2006, which demonstrates the increased interest in monoclonal in new indications, such as central nervous system (CNS) disorders. Pfizer was drawn to Rinat's two of its most advanced monoclonal antibodies that include the RN624 that treats pain by shutting down nerve growth factor (NGF) and RN1219 that clears Alzheimer-causing plaque from the brains of mice, but yet has to enter human trials.

United States, Product development, Drug therapy, Monoclonal antibodies, Nervous system diseases, Rinat Neuroscience Corp.

---

Incretin mimetics vie for slice of type 2 diabetes market

Article Abstract:

New York-based Pfizer has acquired BioRexis Pharmaceutical in order to accomplish further developments in the growing worldwide market in diabetes. Many pharmaceutical and biotech companies are trying to develop long-acting agonists of glucagon-like peptide 1 (GLP-1) mimetics as key components of drug regimens, as it reduces the necessity for insulin injection.

BioRexis Pharmaceutical Corp.

---

Ann Arbor community rallies in wake of Pfizer shutdown

Article Abstract:

The impact of Pfizer shutting down its research facility in Ann Arbor, Michigan, on its employees is discussed. Many startups are initiated by Pfizer's scientists since the closure announcement in January 2007 and many other outside companies are contemplating about starting research operations in Ann Arbor.

Forecasts, trends, outlooks, Plant shutdown, Management dynamics, Management, Forecasts and trends, Market trend/market analysis, Company business management, Facility closures

Similar abstracts:

• Abstracts: Global Hawk UAV readies for new sensors. Sirorsky claims safety edge in PRV bid. Northrop Grumman sees global hawk as 'computer'
• Abstracts: Use of visual perception in estimating static postural stresses: magnitudes and sources of errors. What is demanding lifting job for manual handling workers in Hong Kong?
• Abstracts: How the industry operates. Industry trends. part 2 Banking performance begins to diverge
• Abstracts: S&P credit market services view. Glossary

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.